Saponins as tool for improved targeted tumor therapies.

Abstract:

:Saponins are plant glycosides that consist of a steroid, steroid alkaloid or triterpenoid aglycone and one or more sugar chains that are covalently linked by glycosidic binding to the aglycone. Glucose, galactose, glucuronic acid, xylose and rhamnose are commonly bound monosaccharides. Saponins are found in all organs of a variety of higher plants. Due to the great variability of their structures, diverse functions have been described for distinct saponins; including foaming and pore forming properties as well as selective removal of protozoa from the rumen. The most interesting properties are, however, favorable anti-tumorigenic effects. Several saponins inhibit tumor cell growth by cell cycle arrest and apoptosis with half maximal inhibitory concentrations of down to 0.2 microM. A drawback of saponins in tumor therapy is the non-targeted spreading throughout the whole body. Surprisingly, certain saponins were identified that drastically enhance the efficacy of targeted chimeric toxins bearing the ribosome-inactivating protein saporin as cell-killing moiety. It was demonstrated that this effect is substantially more pronounced on target cells than on non-target cells, thus not only preserving the target specificity of the chimeric toxin but also broadening the therapeutic window with simultaneous dose lowering. This review describes the role of saponins as drug in general, their use as single drug treatment in tumor therapy, their combination with conventional tumor treatment strategies and the synergistic effects with particular targeted tumor therapies that are based on recombinant proteins.

journal_name

Curr Drug Targets

journal_title

Current drug targets

authors

Fuchs H,Bachran D,Panjideh H,Schellmann N,Weng A,Melzig MF,Sutherland M,Bachran C

doi

10.2174/138945009787354584

subject

Has Abstract

pub_date

2009-02-01 00:00:00

pages

140-51

issue

2

eissn

1389-4501

issn

1873-5592

journal_volume

10

pub_type

杂志文章,评审
  • Free Fatty Acid Receptors as New Potential Targets in Colorectal Cancer.

    abstract::Colorectal cancer (CRC) is one of the most common cancers worldwide. In developed countries, its mortality remains high, yet the prevalence has established owing to effective screening programs; however due to the westernization of lifestyle, the incidences in many other countries have increased. Although the treatmen...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450120666191112141901

    authors: Bartoszek A,Fichna J,Tarasiuk A,Binienda A,Fabisiak A,Krajewska JB,Mosińska P,Niewinna K,Salaga M

    更新日期:2020-01-01 00:00:00

  • Targeting PPAR isoforms following CNS injury.

    abstract::A major focus has developed for the discovery of proregenerative and neuroprotective therapeutic agents to help the millions of Americans who receive a CNS injury annually. Tribulations have been encountered along the way due to the complicated set of pathways that are initiated post-injury. To target this complicated...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314070003

    authors: Yonutas HM,Sullivan PG

    更新日期:2013-06-01 00:00:00

  • Antioxidants as a Potential Preventive and Therapeutic Strategy for Cadmium.

    abstract::Epidemiological studies provide a growing number of evidences that chronic exposure to relatively low levels of cadmium (Cd), nowadays taking place in industrialized countries, may cause health hazard. Thus, growing interest has been focused on effective ways of protection from adverse effects of exposure to this heav...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150506114336

    authors: Brzóska MM,Borowska S,Tomczyk M

    更新日期:2016-01-01 00:00:00

  • Inflammasome Activation in Chronic Glomerular Diseases.

    abstract:BACKGROUND:The intracellular multiprotein complex termed the inflammasome functions as a platform of pro-inflammatory cytokine production such as IL-1β and IL-18. Under certain conditions, however, the inflammasome produces non-canonical effects such as induction of cell death, pyroptosis and cell metabolism alteration...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160817103435

    authors: Conley SM,Abais JM,Boini KM,Li PL

    更新日期:2017-01-01 00:00:00

  • Recent advances in targeted anti-vasculature therapy: the neuroblastoma model.

    abstract::Novel anti-vasculature strategies that are emerging for the treatment of cancer and for the inhibition of angiogenesis may be a promising new tool for the adjuvant therapy of malignant tumours. Over the last fifteen years, several reports have been published concerning the relationship between tumour progression and a...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945009789577954

    authors: Pastorino F,Di Paolo D,Loi M,Becherini P,Caffa I,Zorzoli A,Marimpietri D,Carosio R,Perri P,Montaldo PG,Brignole C,Pagnan G,Ribatti D,Allen TM,Ponzoni M

    更新日期:2009-10-01 00:00:00

  • Faecal Microbiota Transplantation in Inflammatory Bowel Disease: Current Concepts and Future Challenges.

    abstract::Dysbiosis has been repeatedly observed in inflammatory bowel disease (IBD) and is now recognized as an essential factor in the gut inflammatory process. IBD is a significant burden to health-care systems, mainly due to treatment-related costs. Available treatments have several limitations: up to 30% of patients are pr...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200602125507

    authors: Zatorski H,Nakov R

    更新日期:2020-01-01 00:00:00

  • Osteopontin; as a target molecule for the treatment of inflammatory diseases.

    abstract::It has been well recognized that inflammatory responses are part of pathogenesis for various disorders such as autoimmune diseases. For example, multiple sclerosis (MS) is an inflammatory demyelinating disease of central nervous system that is presumably caused by activated T cells specific for myelin antigens. Rheuma...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945010790980321

    authors: Morimoto J,Kon S,Matsui Y,Uede T

    更新日期:2010-04-01 00:00:00

  • Try to Remember: Interplay between Memory and Substance Use Disorder.

    abstract::Memories associated with substance use disorders, or substance-associated cues increase the likelihood of craving and relapse during abstinence. There is a growing consensus that manipulation of synaptic plasticity may reduce the strength of substance abuse-related memories. On the biological front, there are new insi...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450118666170622092824

    authors: Mohamed RMP,Kumar J,Yap E,Mohamed IN,Sidi H,Adam RL,Das S

    更新日期:2019-01-01 00:00:00

  • Insight into Pain Modulation: Nociceptors Sensitization and Therapeutic Targets.

    abstract::Pain is a complex multidimensional concept that facilitates the initiation of the signaling cascade in response to any noxious stimuli. Action potential generation in the peripheral nociceptor terminal and its transmission through various types of nociceptors corresponding to mechanical, chemical or thermal stimuli le...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450120666190131114244

    authors: Khan A,Khan S,Kim YS

    更新日期:2019-01-01 00:00:00

  • Chemopreventive and chemotherapeutic potential of curcumin in breast cancer.

    abstract::Breast cancer remains the leading cause of cancer death among females worldwide. It signifies a shift from the previous decade during which the most common cause of cancer death was cervical cancer. Current treatment modalities, including surgery, radiotherapy, and adjuvant chemotherapy or hormone therapy, have not be...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945012804545632

    authors: Sinha D,Biswas J,Sung B,Aggarwal BB,Bishayee A

    更新日期:2012-12-01 00:00:00

  • Ion-Responsive Drug Delivery Systems.

    abstract:BACKGROUND:Some kinds of cations and anions are contained in body fluids such as blood, interstitial fluid, gastrointestinal juice, and tears at relatively high concentration. Ionresponsive drug delivery is available to design the unique dosage formulations which provide optimized drug therapy with effective, safe and ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160527142138

    authors: Yoshida T,Shakushiro K,Sako K

    更新日期:2018-02-08 00:00:00

  • Epigenetic Therapies and Potential Drugs for Treating Human Cancer.

    abstract::Epigenetic modifications ensure the maintenance of normal cellular functions, and their dysregulation is frequently found in many disease states, including cancer. Nowadays, the most studied epigenetic dysregulation associated with tumorigenesis, cancer progression and metastasis refers to the variations in DNA methyl...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200325093104

    authors: Lin SQ,Li X

    更新日期:2020-01-01 00:00:00

  • Expression and functions of galectin-1 in sensory and motoneurons.

    abstract::Galectin-1 (Gal1) was the first identified member of the galectin family of beta-galactosidase-binding proteins. Gal1 has important roles in processes fundamental to growth and survival of an organism, including cell adhesion, cell proliferation and apoptosis, and is expressed in many tissues, including the nervous sy...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450054021864

    authors: Gaudet AD,Steeves JD,Tetzlaff W,Ramer MS

    更新日期:2005-06-01 00:00:00

  • Historical observations on the discovery of platelets, platelet function testing and the first antiplatelet agent.

    abstract::An understanding of the historical paths that have lead to our current state of knowledge in the field of platelet studies can be both illuminating and inspiring. Considering that the existence and function of platelets were initially described just barely over 100 years ago it is exciting to recognize how far our kno...

    journal_title:Current drug targets

    pub_type: 历史文章,杂志文章

    doi:10.2174/138945011797635858

    authors: Steinhubl SR

    更新日期:2011-11-01 00:00:00

  • Novel anti-inflammatory agents in COPD: targeting lung and systemic inflammation.

    abstract::Inflammation plays a central role in chronic obstructive pulmonary disease (COPD). COPD related inflammation is less responsive to inhaled steroids compared to asthma. There are three major novel anti-inflammatory approaches to the management of COPD. The first approach is phosphodiesterase inhibitors, such as roflumi...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314020008

    authors: Loukides S,Bartziokas K,Vestbo J,Singh D

    更新日期:2013-02-01 00:00:00

  • A Review of Aberrant DNA Methylation and Epigenetic Agents Targeting DNA Methyltransferases in Endometriosis.

    abstract:BACKGROUND:Endometriosis (EMS) is a gynecological disease defined by the translocation and growth of endometrial tissue in other tissues or organs outside the uterus. Its clinical manifestations are dysmenorrhea, irregular menstruation, and even infertility. Although EMS is a benign disease, it has the characteristics ...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450121666200228112344

    authors: Ding L,Yang L,Ren C,Zhang H,Lu J,Wang S,Wu Z,Yang Y

    更新日期:2020-01-01 00:00:00

  • TGF-Beta signaling manipulation as potential therapy for IBD.

    abstract::Crohn's disease (CD) and ulcerative colitis (UC), two chronic and relapsing inflammatory bowel diseases (IBD), are supposed to develop in genetically-predisposed individuals as a result of an excessive immune mucosal response directed against normal components of the gut microbiota. There is also evidence that defects...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/13894501113149990157

    authors: Marafini I,Zorzi F,Codazza S,Pallone F,Monteleone G

    更新日期:2013-11-01 00:00:00

  • Improving the embryo implantation via novel molecular targets.

    abstract::With the development of modern assisted reproductive technology(ART), the treatment of infertility and the pregnant outcome by ART have been significantly improved. However, implantation failure, particularly the unexplained repeated implantation failure (RIF), is still the unsolved and principal problem to affect the...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450111314080006

    authors: Li J,Liang X,Chen Z

    更新日期:2013-07-01 00:00:00

  • Phytometabolites Targeting the Warburg Effect in Cancer Cells: A Mechanistic Review.

    abstract::Phytometabolites are functional elements derived from plants and most of them exhibit therapeutic characteristics such as anti-cancer, anti-inflammatory and anti-oxidant effects. Phytometabolites exert their anti-cancer effect by targeting multiple signaling pathways. One of the remarkable phenomena targeted by phytom...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666160401124842

    authors: Hasanpourghadi M,Looi CY,Pandurangan AK,Sethi G,Wong WF,Mustafa MR

    更新日期:2017-01-01 00:00:00

  • Targeting the most upstream site of Wnt signaling pathway provides a strategic advantage for therapy in colorectal cancer.

    abstract::The Wnt signaling pathway has important functions in development, tissue homeostasis, and regeneration. Deregulation of canonical Wnt/beta-catenin signaling is frequently found in various human cancers, particularly in colorectal cancer, and non-canonical Wnt signaling pathways also have been implicated in neoplasia. ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945008784911769

    authors: Qi J,Zhu YQ

    更新日期:2008-07-01 00:00:00

  • Recent advances in active hepatic targeting drug delivery system.

    abstract::Hepatic diseases are turning into one of the few diseases that cannot be effectively cured due to some reasons although various receptors existed in the liver. Currently, several passive targeting delivery systems have been used in the drug/gene delivery for the treatment of hepatic diseases. For example, Zinostatin s...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140309232100

    authors: Wang Y,Du H,Zhai G

    更新日期:2014-06-01 00:00:00

  • Oxidative stress: meeting multiple targets in pathogenesis of diabetic nephropathy.

    abstract::Excessive production of reactive oxygen species is an important mechanism underlying the pathogenesis of diabetes associated macrovascular and microvascular complications including diabetic nephropathy. Diabetic nephropathy is characterized by glomerular enlargement, early albuminuria and progressive glomerulosclerosi...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450115666140321120635

    authors: Arora MK,Singh UK

    更新日期:2014-05-01 00:00:00

  • HIV-1 Tat-Mediated Calcium Dysregulation and Neuronal Dysfunction in Vulnerable Brain Regions.

    abstract::Despite the success of combined antiretroviral therapy, more than half of HIV-1-infected patients in the USA show HIV-associated neurological and neuropsychiatric deficits. This is accompanied by anatomical and functional alterations in vulnerable brain regions of the mesocorticolimbic and nigrostriatal systems that r...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666150531162212

    authors: Hu XT

    更新日期:2016-01-01 00:00:00

  • The Therapeutic Potential of Quercetin in Parkinson's Disease: Insights into its Molecular and Cellular Regulation.

    abstract::Parkinson's disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive death of dopaminergic neurons in the substantia nigra pars compacta (SNc). PD is a multifactorial disorder, with several different factors being suggested to play a synergistic pathophysiological role, inc...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450120666191112155654

    authors: Tamtaji OR,Hadinezhad T,Fallah M,Shahmirzadi AR,Taghizadeh M,Behnam M,Asemi Z

    更新日期:2020-01-01 00:00:00

  • Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders.

    abstract::There exists an immediate need to develop novel medications for the treatment of mood disorders such as bipolar disorder and depression. Initial interest in glycogen synthase kinase-3 (GSK-3) as a target for the treatment of mood disorders arose from the finding that the mood stabilizing drug lithium directly inhibite...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450110607011399

    authors: Gould TD,Picchini AM,Einat H,Manji HK

    更新日期:2006-11-01 00:00:00

  • Nutrition in adult patients with inflammatory bowel disease.

    abstract::Seventy five percent of hospitalized patients with Crohn's disease suffer from malnutrition. One third of Crohn's disease patients have a body mass index below 20. Sixty percent of Crohn's disease patients have sarcopenia. However some inflammatory bowel disease (IBD) patients are obese or suffer from sarcopenic-obesi...

    journal_title:Current drug targets

    pub_type: 杂志文章

    doi:10.2174/1389450115666140930150047

    authors: Hebuterne X,Filippi J,Schneider SM

    更新日期:2014-01-01 00:00:00

  • PDZ Structure and Implication in Selective Drug Design against Cystic Fibrosis.

    abstract::PDZ domains play an essential role in a number of cellular processes by facilitating protein scaffolding and assembly of protein complexes. These domains consist of 80 to 90 amino acids and are found to recognize short C-terminal sequences of target proteins. Protein complex formation between PDZ target molecules can ...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450116666141219120125

    authors: Holcomb J,Spellmon N,Trescott L,Sun F,Li C,Yang Z

    更新日期:2015-01-01 00:00:00

  • Neuroprotective and Neurotoxic Implications of α7 Nicotinic Acetylcholine Receptor and Aβ Interaction: Therapeutic Options in Alzheimer's Disease.

    abstract:BACKGROUND:Alzheimer's disease, a neurodegenerative disorder, is characterized by accumulation of amyloid beta (Aβ) plaques, neurofibrillary tangles and loss of cholinergic neurons. LITERATURE REVIEW:The localization of Aβ plaques particularly in the cholinergic neuron-rich areas has led to the discovery that Aβ binds...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/1389450117666161005145143

    authors: Farhat SM,Ahmed T

    更新日期:2017-01-01 00:00:00

  • Biology of Cox-2: an application in cancer therapeutics.

    abstract::Cyclooxygenase-2 (Cox-2) is an inducible enzyme involved in the conversion of arachidonic acid to prostaglandin and other eicosanoids. Molecular pathology studies have revealed that Cox-2 is over-expressed in cancer and stroma cells during tumor progression, and anti-cancer chemo-radiotherapies induce expression of Co...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945011795677764

    authors: Khan Z,Khan N,Tiwari RP,Sah NK,Prasad GB,Bisen PS

    更新日期:2011-06-01 00:00:00

  • The toll of Toll-like receptors, especially toll-like receptor 2, on murine atherosclerosis.

    abstract::At one time, atherosclerosis was thought to be a simple lipid storage disease. However, it is now recognized as a chronic and progressive inflammation of the arterial wall. Gene deletion experiments in murine models of atherosclerosis that reduce the inflammatory process also reduce disease severity. Identifying the i...

    journal_title:Current drug targets

    pub_type: 杂志文章,评审

    doi:10.2174/138945007783220605

    authors: Curtiss LK,Tobias PS

    更新日期:2007-12-01 00:00:00